D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 103 Citations 36,782 1,063 World Ranking 4365 National Ranking 158

Overview

What is he best known for?

The fields of study Peter D. Siersema is best known for:

  • Cancer
  • Esophagus
  • Stomach

His Disease study falls within the topics of Reflux and Inflammatory bowel disease. His research on Inflammatory bowel disease often connects related areas such as Disease. His research on Internal medicine often connects related areas such as Logistic regression. He conducts interdisciplinary study in the fields of Cancer and Nuclear medicine through his research. In his research, he performs multidisciplinary study on Nuclear medicine and Cancer. Much of his study explores Surgery relationship to Randomized controlled trial. His research brings together the fields of Surgery and Randomized controlled trial. Peter D. Siersema integrates many fields in his works, including Gastroenterology and Endoscopy. In his study, he carries out multidisciplinary Endoscopy and Gastroenterology research.

His most cited work include:

  • Staging investigations for oesophageal cancer: a meta-analysis (423 citations)
  • Factors influencing the miss rate of polyps in a back-to-back colonoscopy study (242 citations)
  • Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity (172 citations)

What are the main themes of his work throughout his whole career to date

Internal medicine and Pathology are two areas of study in which Peter D. Siersema engages in interdisciplinary research. Peter D. Siersema performs integrative Pathology and Internal medicine research in his work. In his research, Peter D. Siersema performs multidisciplinary study on Cancer and Colorectal cancer. He conducts interdisciplinary study in the fields of Colorectal cancer and Cancer through his works. His multidisciplinary approach integrates Surgery and Stent in his work. He combines Esophagus and Esophageal cancer in his research. In his works, he undertakes multidisciplinary study on Esophageal cancer and Esophagus. His Reflux research extends to the thematically linked field of Disease. His work in Reflux is not limited to one particular discipline; it also encompasses Disease.

Peter D. Siersema most often published in these fields:

  • Internal medicine (88.07%)
  • Cancer (53.21%)
  • Surgery (43.12%)

What were the highlights of his more recent work (between 2017-2021)?

  • Surgery (80.00%)
  • Internal medicine (70.00%)
  • Cancer (60.00%)

In recent works Peter D. Siersema was focusing on the following fields of study:

In his study, Aerobic exercise and Clinical Practice is strongly linked to Physical therapy, which falls under the umbrella field of Cardiorespiratory fitness. His Surgery study frequently draws connections to other fields, such as CLIPS. Internal medicine is closely attributed to Logistic regression in his research. Logistic regression is closely attributed to Internal medicine in his work. He integrates several fields in his works, including Cancer and Adenocarcinoma. Peter D. Siersema performs multidisciplinary studies into Adenocarcinoma and Cancer in his work. Peter D. Siersema undertakes interdisciplinary study in the fields of Randomized controlled trial and Meta-analysis through his works. Peter D. Siersema integrates several fields in his works, including Meta-analysis and Randomized controlled trial. In his research, Peter D. Siersema performs multidisciplinary study on Colorectal cancer and Adenoma.

Between 2017 and 2021, his most popular works were:

  • Endoscopic resection of high-risk T1 colorectal carcinoma prior to surgical resection has no adverse effect on long-term outcomes (73 citations)
  • Long-term survival improvement in oesophageal cancer in the Netherlands (48 citations)
  • Time interval between neoadjuvant chemoradiotherapy and surgery for oesophageal or junctional cancer: A nationwide study (34 citations)

In his most recent research, the most cited works focused on:

  • Cancer
  • Colorectal cancer
  • Odds ratio

His research on Internal medicine often connects related topics like Logistic regression. His Logistic regression study typically links adjacent topics like Internal medicine. Surgery is closely attributed to Survival rate in his study. The study of Survival rate is intertwined with the study of Surgery in a number of ways. His work often combines Cancer and Adenocarcinoma studies. Peter D. Siersema incorporates Adenocarcinoma and Cancer in his studies. Chemoradiotherapy and Breast cancer are two areas of study in which he engages in interdisciplinary work. His Breast cancer study frequently draws connections between adjacent fields such as Neoadjuvant therapy. Peter D. Siersema combines Neoadjuvant therapy and Chemoradiotherapy in his research.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium.

Toshiro Sato;Daniel E. Stange;Marc Ferrante;Marc Ferrante;Robert G.J. Vries.
Gastroenterology (2011)

2636 Citations

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

Raffaella M Gadaleta;Karel J van Erpecum;Bas Oldenburg;Ellen C L Willemsen.
Gut (2011)

572 Citations

Staging investigations for oesophageal cancer: a meta-analysis

E P M van Vliet;M H Heijenbrok-Kal;M G M Hunink;E J Kuipers.
British Journal of Cancer (2008)

561 Citations

Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial

Marjolein Y V Homs;Ewout W Steyerberg;Wilhelmina M H Eijkenboom;Hugo W Tilanus.
The Lancet (2004)

505 Citations

Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study

Mirthe Emilie van der Valk;Marie-Josée J Mangen;Max Leenders;Gerard Dijkstra.
Gut (2014)

463 Citations

Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies.

Maurice W M D Lutgens;Martijn G H van Oijen;Geert J M G van der Heijden;Frank P Vleggaar.
Inflammatory Bowel Diseases (2013)

431 Citations

Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction

Marinke Westerterp;Linetta B. Koppert;Christianne J. Buskens;Hugo W. Tilanus.
Virchows Archiv (2005)

403 Citations

High lifetime risk of cancer in primary sclerosing cholangitis

Marian M.H. Claessen;Frank P. Vleggaar;Kristien M.A.J. Tytgat;Peter D. Siersema.
Journal of Hepatology (2009)

377 Citations

Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial.

Suzanne M. Jeurnink;Ewout W. Steyerberg;Jeanin E. van Hooft;Casper H.J. van Eijck.
Gastrointestinal Endoscopy (2010)

374 Citations

Increasing incidence of Barrett’s oesophagus in the general population

E.M. van Soest;Jeanne Dieleman;Peter Siersema;Miriam Sturkenboom.
Gut (2005)

362 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Peter D. Siersema

Hans Clevers

Hans Clevers

Hubrecht Institute for Developmental Biology and Stem Cell Research

Publications: 158

Prateek Sharma

Prateek Sharma

University of Kansas

Publications: 80

Todd H. Baron

Todd H. Baron

University of North Carolina at Chapel Hill

Publications: 80

Ernst J. Kuipers

Ernst J. Kuipers

Erasmus University Rotterdam

Publications: 73

Rebecca C. Fitzgerald

Rebecca C. Fitzgerald

University of Cambridge

Publications: 67

Alessandro Repici

Alessandro Repici

Humanitas University

Publications: 65

Jesper Lagergren

Jesper Lagergren

King's College London

Publications: 63

Marie-Christine Boutron-Ruault

Marie-Christine Boutron-Ruault

University of Paris-Saclay

Publications: 63

Jacques J. Bergman

Jacques J. Bergman

University of Amsterdam

Publications: 62

Nicholas J. Shaheen

Nicholas J. Shaheen

University of North Carolina at Chapel Hill

Publications: 60

Anne Tjønneland

Anne Tjønneland

University of Copenhagen

Publications: 55

Petra H.M. Peeters

Petra H.M. Peeters

Utrecht University

Publications: 54

Kenneth K. Wang

Kenneth K. Wang

Mayo Clinic

Publications: 53

Pagona Lagiou

Pagona Lagiou

National and Kapodistrian University of Athens

Publications: 53

Sachin Wani

Sachin Wani

University of Colorado Anschutz Medical Campus

Publications: 52

Kim Overvad

Kim Overvad

Aarhus University

Publications: 51

Trending Scientists

Peter Ifju

Peter Ifju

University of Florida

Jay L. Zweier

Jay L. Zweier

The Ohio State University

Gilles Patriarche

Gilles Patriarche

Centre national de la recherche scientifique, CNRS

D. M. Denbow

D. M. Denbow

Virginia Tech

Geoffrey E. Pollott

Geoffrey E. Pollott

Royal Veterinary College

Jan V. Colpaert

Jan V. Colpaert

Hasselt University

Shiro Suetsugu

Shiro Suetsugu

Nara Institute of Science and Technology

Joy Bergelson

Joy Bergelson

University of Chicago

Estrella Duque

Estrella Duque

Spanish National Research Council

Lech Wojtczak

Lech Wojtczak

Polish Academy of Sciences

Salvatrice Vizzini

Salvatrice Vizzini

University of Palermo

Eva H. Telzer

Eva H. Telzer

University of North Carolina at Chapel Hill

Caitlin E. Kennedy

Caitlin E. Kennedy

Johns Hopkins University

John B. West

John B. West

University of California, San Diego

Cindy H.P. Sit

Cindy H.P. Sit

Chinese University of Hong Kong

Terry L. Schell

Terry L. Schell

RAND Corporation

Something went wrong. Please try again later.